Three-drug combo reduces risk for lung cancer by 17%, study finds
Taking aspirin, statins and the drug metformin together reduces the risk for lung cancer by 17%, a study published Thursday by the Journal of Thoracic Oncology found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 17, 2020 Category: Consumer Health News Source Type: news

Three common medications lower risk and mortality for lung cancer
(International Association for the Study of Lung Cancer) Combined use of aspirin, statins, and metformin is associated with decreased lung cancerincidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO). The JTO is the official journal of the International Association for the Study of Lung Cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 17, 2020 Category: Cancer & Oncology Source Type: news

Aspirin Alone Preferred Antithrombotic Strategy After TAVI Aspirin Alone Preferred Antithrombotic Strategy After TAVI
Aspirin alone after TAVI significantly reduced bleeding compared with aspirin plus clopidogrel, without increasing thromboembolic events, in the latest results from the POPular TAVI study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 30, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Could Daily Low - Dose Aspirin Hasten Cancer in Seniors?
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 12, 2020 Category: Cancer & Oncology Tags: Family Medicine, Geriatrics, Oncology, News, Source Type: news

Could Daily Low-Dose Aspirin Hasten Cancer in Seniors?
WEDNESDAY, Aug. 12, 2020 -- Taking a daily low-dose aspirin may speed the progression of cancer in the elderly, a new clinical trial shows. Daily aspirin doubled the risk that a person 70 or older would die from a stage 3 cancer, and increased the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 12, 2020 Category: General Medicine Source Type: news

Could Daily Low-Dose Aspirin Hasten Cancer in Seniors?
Title: Could Daily Low-Dose Aspirin Hasten Cancer in Seniors?Category: Health NewsCreated: 8/12/2020 12:00:00 AMLast Editorial Review: 8/12/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 12, 2020 Category: Cancer & Oncology Source Type: news

Shock as ‘painkillers do more harm than good’ says medical watchdog
COMMON painkillers such as paracetamol, aspirin and opioids should not be prescribed to millions of people, the medicines watchdog ruled yesterday. GPs will be told to stop dishing out pills to patients suffering from chronic primary pain which can't be explained by another diagnosis or underlying condition. (Source: Daily Express - Health)
Source: Daily Express - Health - August 4, 2020 Category: Consumer Health News Source Type: news

Women on the pill may face high risks of blood clots if infected with coronavirus
Both coronavirus and high levels of estrogen from the pill, being pregnant or taking HRT raise cot risks, warn doctors at Maine Medical Center and say aspirin or staying off the pill may lower risks. (Source: the Mail online | Health)
Source: the Mail online | Health - July 30, 2020 Category: Consumer Health News Source Type: news

Ticagrelor-Aspirin Combo: Fewer Repeat Strokes, but More Bleeds Ticagrelor-Aspirin Combo: Fewer Repeat Strokes, but More Bleeds
The combination of ticagrelor and aspirin prevents secondary stroke and cuts mortality, but it also appears to increase the risk for severe bleeding.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - July 20, 2020 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news

Ticagrelor-Aspirin Combo: Fewer Repeat Strokes
, Deaths, but More Bleeds (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 20, 2020 Category: General Medicine Source Type: news

Ticagrelor-Aspirin Beneficial for Mild-to-Moderate Stroke, TIA
THURSDAY, July 16, 2020 -- Ticagrelor-aspirin is associated with a reduced risk for the composite of stroke or death within 30 days of mild-to-moderate acute noncardioembolic ischemic stroke or transient ischemic attack (TIA), according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 16, 2020 Category: Pharmaceuticals Source Type: news

Could the willow help us fight cancer?
An ingredient in its bark led to aspirin, now researchers are looking into the properties of another compound in the treeWillow trees are a pharmaceutical treasure trove. The ancient Egyptians used its bark for relieving pain, inflammation and fevers, and science has since shown these medical powers came from an ingredient called salicin, named aftersalix, the Latin name for the tree. That discovery eventually led to the manufacture of aspirin, one of the most widely used medicines in the world.Recently another potential drug has been found in willow, one with anti-cancer powers. Scientists atRothamsted Research in Hertfor...
Source: Guardian Unlimited Science - July 14, 2020 Category: Science Authors: Paul Simons Tags: Science Trees and forests Environment UK news Cancer research Medical research Source Type: news

Massachusetts Scientists Use MicroRNA To Treat ALS For First Time
BOSTON (CBS) – Scientists in Massachusetts have made a potential breakthrough in ALS research. In 1993, Dr. Robert Brown and his team at UMass discovered the first gene linked to familial ALS. His team, working with Massachusetts General Hospital, has now safely treated two people using synthetic microRNA for the first time. The microRNA suppressed and silenced the gene that caused ALS. Dr. Robert Brown and his team have now safely treated two people using synthetic microRNA for the first time. (WBZ-TV) Brown said microRNA is an exciting and powerful method to target ALS cases caused by gene mutations. “This is...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 9, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Featured Health Syndicated CBSN Boston Syndicated Local ALS Source Type: news

Aspirin in honey: dubious COVID-19 'cures' spread in Brazil
In Brazil, home to the world's second worst coronavirus outbreak, one thing seems to be spreading faster than the virus: the suspect, and sometimes strange, strategies to treat it. (Source: Reuters: Health)
Source: Reuters: Health - June 17, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Aspirin Tied to Lasting Reduction in CRC Risk in Lynch Syndrome
MONDAY, June 15, 2020 -- For patients with Lynch syndrome, aspirin is associated with a reduced risk for colorectal cancer during long-term follow-up, according to a study published in the June 13 issue of The Lancet. John Burn, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 15, 2020 Category: Pharmaceuticals Source Type: news

Aspirin reduces long-term colorectal cancer risk in genetically predisposed individuals
(University of Jyv ä skyl ä - Jyv ä skyl ä n yliopisto) Aspirin reduces colorectal cancer risk by half in individuals at high genetic risk. Preventive efficacy is prolonged for 10-20 years after treatment with aspirin. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2020 Category: Cancer & Oncology Source Type: news

An aspirin a day keeps the bowel doctor away
(Newcastle University) A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2020 Category: Cancer & Oncology Source Type: news

Low-Dose Aspirin Lowers CVD Risk but Raises Bleeding Risk
WEDNESDAY, June 10, 2020 -- Low-dose aspirin significantly lowers cardiovascular disease (CVD) risk but increases the risk for bleeding, according to a review published online June 2 in the British Journal of Clinical Pharmacology. Nicola Veronese,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2020 Category: Pharmaceuticals Source Type: news

Medtronic Expands Indications for the Resolute Onyx DES in Europe
Medtronic has scored CE mark for a unique indication for the Resolute Onyx drug-eluting stent. The Dublin-based company said the approval was for a DAPT indication for high bleeding risk (HBR) patients. The firm said for HBR patients whose bleeding risk may be increased by taking longer DAPT regimens (a combination of aspirin and anti-clotting medication), this new, indication allows physicians to recommend a shorter, one-month regimen of DAPT, following a percutaneous coronary intervention (PCI) with Resolute Onyx. The indication is based on results from the Onyx ONE Global Study, a prospective, randomized, one-month DAPT...
Source: MDDI - June 8, 2020 Category: Medical Devices Authors: MDDI Staff Tags: Regulatory and Compliance Cardiovascular Source Type: news

Daily Aspirin Not A Good Choice for Healthy People
Title: Daily Aspirin Not A Good Choice for Healthy PeopleCategory: Health NewsCreated: 6/4/2020 12:00:00 AMLast Editorial Review: 6/5/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 5, 2020 Category: Cardiology Source Type: news

Low-Dose Aspirin Does Not Prevent Depression in Older Adults
THURSDAY, June 4, 2020 -- For older adults, low-dose aspirin does not reduce the risk for depression, according to a study published online June 3 in JAMA Psychiatry. Michael Berk, M.B.B.Ch., Ph.D., from the Deakin University School of Medicine in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2020 Category: Pharmaceuticals Source Type: news

Health Highlights: June 4, 2020
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Daily Aspirin Not A Good Choice for Healthy People Taking a daily aspirin to prevent heart disease has more risks than benefits in healthy... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 4, 2020 Category: General Medicine Source Type: news

Healthy People Shouldn ’ t Take Daily Aspirin To Prevent Heart Disease, Review Finds
(CNN) — Still taking a daily aspirin to ward off heart attacks? You might want to think again, according to a new review. Aspirin is still one of the most commonly used medications in the world, even though it’s no longer recommended as a preventative by many health authorities. There is no evidence that low-dose aspirin — less than 325 milligrams a day — should be taken by most adults in good cardiovascular health, according to a new review of existing research that published Wednesday in the British Journal of Clinical Pharmacology. The review, which focused on the risks and benefits of low-dose d...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 3, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News aspirin CNN Source Type: news

Healthy people shouldn't take daily aspirin to prevent heart disease, review finds
There's no evidence that a daily aspirin should be taken by most adults in good cardiovascular health, according to a new review. The risk of a major bleeding event due to the drug's blood thinning effects outweighs the benefit, the research said. (Source: CNN.com - Health)
Source: CNN.com - Health - June 3, 2020 Category: Consumer Health News Source Type: news

What are the risks and benefits of low-dose aspirin?
(Wiley) Low-dose aspirin significantly lowers cardiovascular disease risk but increases the risk of bleeding, according to a review published in the British Journal of Clinical Pharmacology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 3, 2020 Category: International Medicine & Public Health Source Type: news

Two paths better than one for treating patients with heart stents
(University of Alberta Faculty of Medicine& Dentistry) Pairing a blood-thinning drug with aspirin daily for patients who have an angioplasty with a stent can contribute to better health outcomes, including lower risk of death, than aspirin alone, according to a recent study by cardiologists at the University of Alberta and Mazankowski Alberta Heart Institute. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 28, 2020 Category: International Medicine & Public Health Source Type: news

Study: Cannabis plant contains molecules that are 30 times more effective at reducing inflammation than aspirin
(Natural News) Conditions that cause chronic pain can be difficult to deal with. Severe and persistent pain not only affects a person’s ability to perform his daily tasks, it also reduces his quality of life. Often, physicians prescribe strong opioids that can block pain receptors in the brain to help patients get pain relief. However,... (Source: NaturalNews.com)
Source: NaturalNews.com - May 25, 2020 Category: Consumer Health News Source Type: news

Women Less Likely to Receive Heart Meds in Primary Care Women Less Likely to Receive Heart Meds in Primary Care
There are clear gender differences in the medication prescribed in primary care to adults with or at high risk for heart disease, with women less apt than men to receive aspirin and statins, a new study indicates.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Half of pregnant women at risk of pre-eclampsia missing out on aspirin that can help prevent it
Aspirin has been used for decades to reduce the risk of pre-eclampsia, which leads to dangerously high blood pressure and threatens the life of both mother and baby. (Source: the Mail online | Health)
Source: the Mail online | Health - May 22, 2020 Category: Consumer Health News Source Type: news

Some recommended cardiovascular medications prescribed less frequently to women
(American Heart Association) In primary care, sex differences for recommended cardiovascular (CVD) prescriptions were found for patients who were at high risk or who had CVD. Women were less likely than men to receive cholesterol-lowering medicines and aspirin, yet equally likely to receive blood-pressure-lowering medications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 20, 2020 Category: International Medicine & Public Health Source Type: news

Taking aspirin daily to prevent heart disease may do more harm than good, say scientists
(Natural News) Aspirin is one of the most widely used medications in the U.S., both as a prescription drug and as an over-the-counter drug. According to the Drug Facts label on medication products, aspirin can be used to relieve minor complaints, such as headaches, pain, swelling and fever. Aspirin is also prescribed by physicians for other purposes... (Source: NaturalNews.com)
Source: NaturalNews.com - May 19, 2020 Category: Consumer Health News Source Type: news

Statin, Aspirin Uptake Low With Peripheral Artery Disease, Stroke
MONDAY, May 18, 2020 -- Uptake of guideline-directed preventive therapies is lower for patients with stroke and peripheral artery disease (PAD) compared with those with coronary artery disease (CAD), according to a study presented at the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 18, 2020 Category: Pharmaceuticals Source Type: news

Regular Aspirin Use Tied to Lower Risk for Digestive Tract Cancers
Favorable effect increases with longer duration of use, and, for colorectal cancer, with increasing dose (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 15, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Regular Aspirin Use Tied to Lower Risk for Digestive Tract Cancers
FRIDAY, May 15, 2020 -- Regular aspirin use is associated with a lower risk for colorectal and other digestive tract cancers, according to a review published in the May 1 issue of the Annals of Oncology. Cristina Bosetti, Ph.D., from the Istituto... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 15, 2020 Category: Pharmaceuticals Source Type: news

NSAIDs/Aspirin and Post-colonoscopy Colorectal Cancer Risk NSAIDs/Aspirin and Post-colonoscopy Colorectal Cancer Risk
Do aspirin or NSAIDs reduce colorectal cancer risk after a negative baseline colonoscopy?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 11, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Temple finds link between blood vessel inflammation, malfunctioning cellular powerhouses
(Temple University Health System) In new research, scientists at the Lewis Katz School of Medicine at Temple University have uncovered a novel mechanism by which abnormalities in mitochondrial fission in endothelial cells contribute to inflammation and oxidative stress in the cardiovascular system. They further show how the fission-fusion balance can be stabilized to lower inflammation using salicylate, the main active ingredient in everyday pain-relieving drugs like aspirin. The groundbreaking research was published online May 11, 2020 in the journal Hypertension. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2020 Category: International Medicine & Public Health Source Type: news

AUGUSTUS: After ACS or PCI, Aspirin Gives AFib Patients Scant Benefit AUGUSTUS: After ACS or PCI, Aspirin Gives AFib Patients Scant Benefit
When patients with atrial fibrillation have an acute coronary syndrome event or undergo PCI, benefit from a triple antithrombotic regimen is only about 30 days, a post hoc analysis of AUGUSTUS shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 27, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Aspirin may lower the risks of digestive tract cancers by 22 to 38 percent, a meta-analysis suggests
For all types, the longer people had taken the pain reliever, the better their odds of not developing colorectal, stomach and similar cancers. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 27, 2020 Category: Consumer Health News Authors: Linda Searing Source Type: news

The association between aspirin use and depression: a systematic review and meta-analysis of observational studies - Kim HB, Kim JS, Jung JG.
PURPOSE: Many clinical trials and observational studies have been conducted under the premise that the anti-inflammatory effect of aspirin may prevent depression. These studies, however, showed inconsistent results. To inspect the association between aspir... (Source: SafetyLit)
Source: SafetyLit - April 24, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Daily Aspirin Tied to Lower Risk of Various Digestive Cancers
Regular aspirin use was associated with a reduced risk for colon, rectal, stomach, esophageal, liver, gallbladder and pancreatic cancers. (Source: NYT Health)
Source: NYT Health - April 21, 2020 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Colon and Colorectal Cancer Pancreatic Cancer Liver Cancer Aspirin Esophageal Cancer Gallbladder Stomach Cancer Source Type: news

Regular Aspirin Use and Reduced Risk of Pancreatic, Liver Cancer Regular Aspirin Use and Reduced Risk of Pancreatic, Liver Cancer
Regular aspirin use was associated with a reduced risk of cancer at all gastrointestinal sites, including pancreatic and hepatobiliary cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 16, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Low - Dose Aspirin Might Lower Odds for Digestive Cancers
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 16, 2020 Category: Cancer & Oncology Tags: Family Medicine, Oncology, News, Source Type: news

Low-Dose Aspirin Might Lower Odds for Digestive Cancers
THURSDAY, April 16, 2020 -- Low-dose aspirin may reduce the risk of several types of digestive tract cancers, according to a team of researchers in Europe. For the new study, the researchers analyzed 113 studies investigating colon/rectal... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 16, 2020 Category: General Medicine Source Type: news

Taking aspirin just once a week could slash risk of some cancers by nearly 40 percent
CANCER Research UK confirms there are around 1,000 new cases of the disease every day in the UK. New research has found that taking aspirin on a regular basis could slash a person's risk of developing the disease by 40 percent. (Source: Daily Express - Health)
Source: Daily Express - Health - April 16, 2020 Category: Consumer Health News Source Type: news

Low-Dose Aspirin Might Lower Odds for Digestive Cancers
Title: Low-Dose Aspirin Might Lower Odds for Digestive CancersCategory: Health NewsCreated: 4/16/2020 12:00:00 AMLast Editorial Review: 4/16/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 16, 2020 Category: Cancer & Oncology Source Type: news

Taking aspirin once a week can cut the risk of getting several types of cancer, scientists claim
The scientific review, by Milan University in Italy, looked at a range of studies and found regular use of aspirin appeared to reduce the risk of getting stomach and oesophagus cancers by around a third. (Source: the Mail online | Health)
Source: the Mail online | Health - April 16, 2020 Category: Consumer Health News Source Type: news

Recommended Statement for Over-the-Counter Aspirin-Containing Drug Products Labeled With Cardiovascular Related Imagery Guidance for Industry
Compliance (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 15, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

TWILIGHT-COMPLEX: Tap Ticagrelor Monotherapy Early After Complex PCI TWILIGHT-COMPLEX: Tap Ticagrelor Monotherapy Early After Complex PCI
Patients who underwent complex PCI for acute coronary syndrome followed by 3 months of dual-antiplatelet therapy with ticagrelor fared significantly better after the discontinuation of aspirin.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 15, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Aspirin linked to reduction in risk of several cancers of the digestive tract
(European Society for Medical Oncology) The largest and most comprehensive analysis to date of the link between aspirin and cancers of the digestive tract has shown that it is associated not only with a significant reduction in the risk of developing bowel cancer but also of several other cancers that almost invariably fatal, such as pancreatic and liver cancers. The study is published in Annals of Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2020 Category: Cancer & Oncology Source Type: news

Johnson & Johnson Reports 2020 First-Quarter Results:
New Brunswick, N.J. (April 14, 2020) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2020. The Company also announced earlier today that its Board of Directors declared a 6.3% increase in the quarterly dividend rate, from $0.95 per share to $1.01 per share. At the new rate, the indicated dividend on an annual basis is $4.04 per share compared to the previous rate of $3.80 per share. “With Johnson & Johnson’s century-plus history of leading in times of great challenge, we are mobilizing our resources across the Company in the fight against the COVID-19 pandemic,” sai...
Source: Johnson and Johnson - April 14, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news